+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

Single-target MET TKIs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Single-target MET TKIs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Vebreltinib Enteric Capsules Market - Global Forecast 2026-2032 - Product Thumbnail Image

Vebreltinib Enteric Capsules Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Humanized Bispecific Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Humanized Bispecific Antibodies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
Blood Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Blood Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
Liver Cancer Market Report 2026 - Product Thumbnail Image

Liver Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Desmoid Tumors Market Report 2026 - Product Thumbnail Image

Desmoid Tumors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drugs for Immunotherapy Market Report 2026 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
BCL-2 Inhibitors Market Report 2026 - Product Thumbnail Image

BCL-2 Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Penile Cancer Market Report 2026 - Product Thumbnail Image

Penile Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Chemotherapy Market Report 2026 - Product Thumbnail Image

Chemotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Liver Cancer Therapeutics Market Report 2026 - Product Thumbnail Image

Liver Cancer Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
MSI-H and dMMR Market Report 2026 - Product Thumbnail Image

MSI-H and dMMR Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Gastrointestinal Cancer Market Report 2026 - Product Thumbnail Image

Gastrointestinal Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Liver Cancer Drug Market Report 2026 - Product Thumbnail Image

Liver Cancer Drug Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Compounding Chemotherapy - Global Strategic Business Report - Product Thumbnail Image

Compounding Chemotherapy - Global Strategic Business Report

  • Report
  • October 2026
  • 470 Pages
  • Global
From
Liver Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 287 Pages
  • Global
From
Targeted Cancer Therapy - Global Strategic Business Report - Product Thumbnail Image

Targeted Cancer Therapy - Global Strategic Business Report

  • Report
  • October 2026
  • 396 Pages
  • Global
From
From
Nasopharynx Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Nasopharynx Cancer Market - Global Strategic Business Report

  • Report
  • October 2026
  • 287 Pages
  • Global
From
Gastric Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer Market - Global Strategic Business Report

  • Report
  • October 2026
  • 582 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more